Healthcare organizations can maintain 340B compliance by keeping eligibility information accurate, preventing diversion and duplicate discounts, maintaining reliable records, and regularly monitoring their purchasing, dispensing, and billing processes. A strong compliance program combines clear policies, trained staff, regular audits, and consistent data review.

The 340B Drug Pricing Program gives eligible healthcare organizations access to covered outpatient drugs at discounted prices. The savings can help organizations stretch limited resources and support patient care. But participating in the program also comes with responsibilities. Small gaps in processes or data can create compliance risks.

Understand the 340B Compliance Requirements

The first step is knowing exactly what the program requires.

Covered entities must keep their information in the HRSA Office of Pharmacy Affairs Information System (OPAIS) accurate and current. They must also recertify their eligibility each year and maintain records that demonstrate compliance. HRSA specifically identifies eligibility, diversion, duplicate discounts, and other program requirements as areas subject to audit.

This means compliance should not be treated as a once-a-year task. It needs to be part of the organization's normal pharmacy, billing, purchasing, and administrative processes.

A good starting point is to document:

• Which locations are registered in the program

• Which pharmacies participate

• How patient eligibility is determined

• How 340B drugs are purchased and dispensed

• How Medicaid claims are handled

• Who is responsible for compliance monitoring

• How issues are documented and corrected

Clear ownership is especially important. If no one knows who is responsible for reviewing a process, problems can remain unnoticed.

Prevent Drug Diversion

Drug diversion is one of the major areas of concern in 340B compliance.

In simple terms, 340B drugs cannot be transferred or resold to patients who do not meet the applicable program requirements. Organizations therefore need a reliable process for determining whether a prescription or drug administration qualifies for 340B treatment.

This can become difficult when an organization has multiple facilities, providers, pharmacies, and patient systems.

For example, a patient may receive care at different locations within the same health system. If systems do not communicate properly, staff may have difficulty confirming whether the transaction meets the organization's 340B policies.

Healthcare organizations should regularly review patient eligibility rules and compare dispensing information with patient records. HRSA provides patient-definition resources and uses eligibility and diversion as part of its program integrity reviews.

Monitor Duplicate Discount Risks

Another important part of 340B program compliance is preventing duplicate discounts.

A duplicate discount can occur when a covered drug receives a 340B discount and a Medicaid rebate for the same drug. Federal law prohibits manufacturers from having to provide both discounts for the same drug.

Organizations should have clear processes for determining how Medicaid fee-for-service claims are handled. Covered entities must indicate whether they will use 340B drugs for Medicaid fee-for-service patients or purchase those drugs through other mechanisms.

This is an area where accurate data matters. Purchasing records, dispensing records, claims information, and Medicaid data should align. When these systems operate separately, manual errors become more likely.

Use Technology for 340B Compliance Monitoring

Technology can make 340B compliance management more consistent.

A well-designed system can bring data from different sources together and help teams identify unusual transactions before they become larger problems. Depending on the organization's setup, technology can support:

• 340B eligibility checks

• Purchasing and dispensing reconciliation

• Medicaid claim monitoring

• Duplicate discount detection

• Diversion monitoring

• Contract pharmacy oversight

• Exception reporting

• Audit documentation

• Compliance dashboards

The goal is not to replace human oversight. It is to give compliance teams better visibility into what is happening.

For organizations reviewing their current processes, a structured 340B program health check can also help identify areas that may need closer attention.

Keep Contract Pharmacies Under Review

Contract pharmacy arrangements can add another layer of complexity.

The covered entity remains responsible for ensuring its contract pharmacy arrangements meet applicable requirements, including safeguards against diversion and duplicate discounts. HRSA recommends quarterly internal audits and annual independent audits of utilized contract pharmacies, or more frequently when necessary. It also recommends written policies and procedures and reconciliation of dispensing, purchasing, and billing records.

Organizations should therefore avoid treating a contract pharmacy as a separate compliance responsibility.

Regular reviews should look at whether:

• Patient eligibility is being determined correctly

• Dispensing records match purchasing activity

• Billing data is accurate

• Medicaid transactions are handled according to policy

• Exceptions are investigated and documented

These reviews can reveal problems while they are still manageable.

Make Audit Readiness Part of Normal Operations

A 340B audit should not be the first time an organization reviews its compliance records.

HRSA audits can examine eligibility requirements, diversion, duplicate discounts, and other program requirements. Auditors may request documentation related to policies, procedures, and internal controls.

That makes audit readiness an ongoing activity.

Organizations should maintain organized records showing how their processes work and how compliance is monitored. Policies should be current, staff should understand their responsibilities, and corrective actions should be documented.

A simple internal audit schedule can help. For example, teams can review high-risk transactions monthly, perform broader compliance reviews quarterly, and conduct more comprehensive assessments annually.

Train Staff and Update Policies

Even strong technology cannot fix a process that employees do not understand.

Pharmacy teams, billing staff, compliance professionals, IT teams, and other employees involved in 340B operations should understand how their work affects compliance.

Training should cover the organization's policies, patient eligibility, purchasing procedures, Medicaid billing, contract pharmacy processes, and escalation procedures.

Policies should also be reviewed whenever there are meaningful changes to systems, locations, pharmacy arrangements, or program requirements.

Fix Problems Quickly

Finding a compliance issue is not the end of the process. The organization also needs a clear way to investigate and correct it.

When an exception appears, the team should determine:

1. What happened?

2. Which transactions were affected?

3. Why did the issue occur?

4. Was the problem isolated or ongoing?

5. What corrective action is needed?

6. How will the organization prevent it from happening again?

If an organization identifies diversion, duplicate discounts, or another compliance problem that it cannot reasonably resolve through its existing controls, HRSA provides a self-disclosure process for covered entities.

Common Questions About 340B Compliance

How often should a healthcare organization review 340B compliance?

Compliance should be monitored continuously rather than only during an annual review. The exact frequency can depend on the organization's size, systems, pharmacy arrangements, and risk areas. HRSA recommends quarterly internal and annual independent audits for utilized contract pharmacies.

What are the biggest 340B compliance risks?

Common risk areas include inaccurate eligibility information, drug diversion, duplicate discounts, weak contract pharmacy oversight, incomplete records, and outdated policies or system configurations.

Can technology prevent all 340B compliance problems?

No. Technology can improve data validation, monitoring, reporting, and reconciliation, but organizations still need effective policies, trained employees, appropriate controls, and human review.

Why is data validation important for 340B compliance?

340B decisions often depend on information from multiple systems. Validating purchasing, dispensing, patient, and billing data can help organizations identify inconsistencies and investigate potential compliance issues earlier.

Conclusion

Maintaining 340B compliance requires more than checking a few boxes each year. Healthcare organizations need reliable data, clear processes, regular monitoring, trained staff, and strong oversight of pharmacies and transactions.

The best approach is to make compliance part of everyday operations. When organizations continuously review their data, document their processes, address exceptions quickly, and stay prepared for audits, they can reduce unnecessary compliance risks while managing their 340B program more effectively.